Consultancy AlixPartners looked at what weight loss drugs mean for clothing companies, as shoppers on GLP-1s change sizes and buying habits.
Recap by typeshit. Full story at Chain Store Age.
General exercise advice aimed at GLP-1 users, shared on Facebook with no study or expert named in the material available.
Gilead takes global rights to the Shanghai biotech's program, led by HCXT-2001, an oral peptide that could compete with injected IBD drugs.
A Facebook promo for a podcast episode on the ripple effects of GLP-1 consumers across businesses. Few details beyond the pitch.
10:49
xitsnemox posts a short check-in from week 14 on oral Wegovy, two weeks after stepping up to the 25mg tablet. A personal account, not medical advice.
8:32
Archibald follows up his earlier retatrutide video with a look at its uses. Retatrutide is still an investigational drug and is not FDA approved.
A shared research summary evaluating how GLP-1 receptor agonists affect deaths and hospital stays in people with type 2 diabetes. Details are thin here.
Loading…